Tenax Therapeutics TENX 深 沪
等待开盘 05-21 09:30:00 美东时间
12.00
+0.525
+4.58%
华盛通- 最 高12.18
- 今 开11.51
- 成交量 32.79万股
- 最 低 11.51
- 昨 收 11.475
- 总市值 3.18亿
- 52周最高 18.38
- 市盈率 静 --
- 换手率 1.24%
- 52周最低 5.34
- 委 比 57.79%
- 总股本 2652.52万
- 历史最高 274560.00
- 量 比 0.60
- 振 幅 5.84%
- 历史最低 4.63
- 每 手 1
- 风险率 3.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Tenax Therapeutics Q1 EPS $(0.35) Beats $(0.58) Estimate
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.58) by 39.66 percent. This is a 25 percent decrease over losses of $(0.28) per share from
05-12 19:08
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tenax Therapeutics granted stock options to purchase 657,500 shares to four new employees as inducements for their employment. The options vest over four years, with 25% vesting after one year and the rest vesting monthly thereafter. The awards were approved by the Board's Compensation Committee and granted outside the Company's equity incentive plan, in accordance with Nasdaq Listing Rule 5635(c)(4).
05-08 20:05
Tenax Therapeutics appoints Thomas Staab as chief financial officer
Tenax Therapeutics (TENX) has appointed Thomas Staab as chief financial officer, effective May 11, 2026, replacing Thomas McGauley. Staab brings over 25 years of leadership experience across managemen...
04-22 19:38
Tenax Therapeutics names new CFO
Tenax Therapeutics (TENX) appointed Thomas R. Staab II as CFo, effective May 11, 2026, replacing interim CFO Thomas McGauley. Staab brings more than 25 years of financial leadership experience in the ...
04-22 19:18
Tenax Therapeutics Files Prospectus For Offering $300M Securities
https://www.sec.gov/Archives/edgar/data/34956/000165495426002661/tennx_s3.htm
03-24 23:44
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Cantor Fitzgerald Initiates Coverage On Tenax Therapeutics with Overweight Rating, Announces Price Target of $35
Cantor Fitzgerald analyst Olivia Brayer Saunders initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Overweight rating and announces Price Target of $35.
03-17 20:40
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
